Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency (Q39203683)
Jump to navigation
Jump to search
scientific article published on 25 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency |
scientific article published on 25 February 2013 |
Statements
1 reference
Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency (English)
1 reference
Marie Vincent
1 reference
Anne Bessard
1 reference
Denis Cochonneau
1 reference
Géraldine Teppaz
1 reference
Véronique Solé
1 reference
Mike Maillasson
1 reference
Stéphane Birklé
1 reference
Yannick Jacques
1 reference
25 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference